GLS and breast cancer: Klebsiella pneumoniae glutaminase was able to reduce the viability of HeLa cells in a dose-dependent manner, with an IC50 value of 305.78 μg/ml in human hepatocellular carcinoma and an IC50 value of 400.51 μg/ml in breast cancer cell lines.